Cited by 761Nitric Oxide and Endothelin EffectsDiabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation

Open access

Steinberg, H O, Tarshoby, M, Monestel, R, Hook, G, Cronin, J, Johnson, A, Bayazeed, B, Baron, A D·1997·Journal of Clinical Investigation

DOI 10.1172/jci119636PMC PMC508300

Open this paper in CoChat — free account Open PDF

Abstract

We have recently shown that insulin-resistant obese subjects exhibit impaired endothelial function. Here, we test the hypothesis that elevation of circulating FFA to levels seen in insulin-resistant subjects can impair endothelial function. We studied leg blood flow responses to graded intrafemoral artery infusions of the endothelium-dependent vasodilator methacholine chloride (Mch) or the endothelium-independent vasodilator sodium nitroprusside during the infusion of saline and after raising systemic circulating FFA levels exogenously via a low- or high-dose infusion of Intralipid plus heparin or endogenously by an infusion of somatostatin (SRIF) to produce insulinopenia in groups of lean healthy humans. After 2 h of infusion of Intralipid plus heparin, FFA levels increased from 562+/-95 to 1,303+/-188 micromol, and from 350+/-35 to 3,850+/-371 micromol (P < 0.001) vs. saline for both low- and high-dose groups, respectively. Mch-induced vasodilation relative to baseline was reduced by approximately 20% in response to the raised FFA levels in both groups (P < 0.05, saline vs. FFA, ANOVA). In contrast, similar FFA elevation did not change leg blood flow responses to sodium nitroprusside. During the 2-h SRIF infusion, insulin levels fell, and FFA levels rose from 474+/-22 to 1,042+/-116 micromol (P < 0.01); Mch-induced vasodilation was reduced by approximately 20% (P < 0.02, saline vs. SRIF, ANOVA). Replacement of basal insulin levels during SRIF resulted in a fall of FFA levels from 545+/-47 to 228+/-61 micromol, and prevented the impairment of Mch-induced vasodilation seen with SRIF alone. In conclusion, (a) elevated circulating FFA levels cause endothelial dysfunction, and (b) impaired endothelial function in insulin-resistant humans may be secondary to the elevated FFA concentrations observed in these patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci119636

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance
Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118709 · Cited by 1,687 · cited 10×
“We found, however, that serum cholesterol and blood pressure elevations could account for only a small proportion of the endothelial dysfunction displayed in these subjects (4).”
BackgroundResultInfluentialSelf-citation
Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.
Steinberg, H. O., Brechtel, G., Johnson, A., Fineberg, N. S., & Baron, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117433 · Cited by 1,216
Self-citation
Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance.
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114644 · Cited by 930
Self-citation
Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans
Baron, A., Brechtel, G., Wallace, P., & Edelman, S. V. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.255.6.e769 · Cited by 645
Self-citation
Colorimetric ultramicro method for the determination of free fatty acids
Novák, M. (1965) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39315-9 · Cited by 639
Impaired Insulin-Mediated Skeletal Muscle Blood Flow in Patients With NIDDM
Laakso, M., Edelman, S. V., Brechtel, G., & Baron, A. D. (1992) · Diabetes · doi:10.2337/diab.41.9.1076 · Cited by 470 · cited 1×
“Interestingly, this insulin effect is either blunted or absent in obese insulin-resistant subjects with or without non-insulin-dependent diabetes mellitus (NIDDM) 1 (1, 3).”
BackgroundSelf-citation
THE VASCULAR BIOLOGY OF NITRIC OXIDE AND ITS ROLE IN ATHEROGENESIS
Lloyd‐Jones, D. M., & Bloch, K. D. (1996) · Annual Review of Medicine · doi:10.1146/annurev.med.47.1.365 · Cited by 243
Syndrome X: 6 years later.
Reaven, G. M. (1994) · PubMed · Cited by 241
Oleic Acid Inhibits Endothelial Nitric Oxide Synthase by a Protein Kinase C–Independent Mechanism
Davda, R. K., Stepniakowski, K. T., Lü, G., Ullian, M. E., Goodfriend, T. L., & Egan, B. M. (1995) · Hypertension · doi:10.1161/01.hyp.26.5.764 · Cited by 216
Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM
Laakso, M., Edelman, S. V., Brechtel, G., et al. (1992) · Diabetes · doi:10.2337/diabetes.41.9.1076 · Cited by 145

Show all 16 references

Sorted by citations

Items 301–400 of 761

Free fatty acids normalize a rosiglitazone-induced visfatin release
Haider, D. G., Mittermayer, F., Schaller, G., Artwohl, M., Baumgartner-Parzer, S. M., Prager, G., Roden, M., & Wolzt, M. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00109.2006 · Cited by 39
Comparison of 1-(11)C-glucose and (18)F-FDG for quantifying myocardial glucose use with PET.
Herrero, P., Sharp, T. L., Dence, C. S., Haraden, B. M., & Gropler, R. J. (2002) · PubMed · Cited by 42
Up-regulation of endothelial nitric oxide activity as a central strategy for prevention of ischemic stroke – Just say NO to stroke!
McCarty, M. F. (2000) · Medical Hypotheses · doi:10.1054/mehy.2000.1075 · Cited by 43
Preeclampsia and Obesity—The Preventive Role of Exercise
Poniedziałek‐Czajkowska, E., Mierzyński, R., & Leszczyńska‐Gorzelak, B. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20021267 · Cited by 73
Contributions of dysglycaemia, obesity, and insulin resistance to impaired endothelium‐dependent vasodilation in humans
Han, K., Patel, Y. R., Lteif, A. A., Chisholm, R., & Mather, K. J. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1183 · Cited by 41
Effect of Sacubitril/Valsartan on Exercise-Induced Lipid Metabolism in Patients With Obesity and Hypertension
Engeli, S., Stinkens, R., Heise, T., May, M., Goossens, G. H., Blaak, E. E., Havekes, B., Jax, T. W., Albrecht, D., Pal, P., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.10224 · Cited by 42
Mediating Effects of Inflammatory Biomarkers on Insulin Resistance Associated with Obesity
Wexler, D. J., Hu, F. B., Manson, J. E., Rifai, N., & Meigs, J. B. (2005) · Obesity Research · doi:10.1038/oby.2005.216 · Cited by 41
DHA-rich fish oil reverses the detrimental effects of saturated fatty acids on postprandial vascular reactivity
Newens, K. J., Thompson, A. K., Jackson, K. G., Wright, J., & Williams, C. M. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.009233 · Cited by 41
Obesity and diabetes as risk factors for coronary artery disease: from the epidemiological aspect to the initial vascular mechanisms
Sundell, J. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00375.x · Cited by 41
GLP‐1 and insulin regulation of skeletal and cardiac muscle microvascular perfusion in type 2 diabetes
Love, K. M., Liu, J., Regensteiner, J. G., Reusch, J. E. B., & Liu, Z. (2020) · Journal of Diabetes · doi:10.1111/1753-0407.13045 · Cited by 40
Blood glucose management in the patient undergoing cardiac surgery: A review
Reddy, P. P. (2014) · World Journal of Cardiology · doi:10.4330/wjc.v6.i11.1209 · Cited by 41
The vascular endothelium in diabetes—a therapeutic target?
Mather, K. J. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9237-9 · Cited by 41
Smoking in diabetic nephropathy: sparks in the fuel tank?
Chakkarwar, V. A. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i12.186 · Cited by 40
Stress and Metabolism
Seematter, G., Binnert, C., & Tappy, L. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.8 · Cited by 39
Protective effect and mechanism of Qishiwei Zhenzhu pills on cerebral ischemia-reperfusion injury via blood-brain barrier and metabonomics
Xu, M., Wu, R., Liang, Y. J., Fu, K., Zhou, Y. L., Li, X., Wu, L., & Wang, Z. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110723 · Cited by 39
Serum non-esterified very long-chain PUFA are associated with markers of endothelial dysfunction
Berstad, P. M., Seljeflot, I., Meyer, H. E., Hjerkinn, E. M., Arnesen, H., & Pedersen, J. I. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00067-9 · Cited by 39
Vascular Response to Angiotensin II in Upper Body Obesity
Nielsen, S., Halliwill, J. R., Joyner, M. J., & Jensen, M. D. (2004) · Hypertension · doi:10.1161/01.hyp.0000142111.67601.6b · Cited by 40
Transcription-Modulating Drugs
Kurtz, T. W., & Gardner, D. G. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.380 · Cited by 39
O endotélio na síndrome metabólica
Bahia, L., Kraemer‐Aguiar, L. G., Villela, N. R., Bottino, D. A., & Bouskela, E. (2006) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302006000200015 · Cited by 38
Rosiglitazone Prevents Free Fatty Acid-Induced Vascular Endothelial Dysfunction
Mittermayer, F., Schaller, G., Pleiner, J., Krzyżanowska, K., Kapiotis, S., Roden, M., & Wolzt, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2130 · Cited by 38
Multiple mechanisms involved in obesity-induced hypertension
Antic, V., Dulloo, A. G., & Montani, J. (2003) · Heart Lung and Circulation · doi:10.1046/j.1444-2892.2003.00200.x · Cited by 39
Insulin Improves Alveolar-Capillary Membrane Gas Conductance in Type 2 Diabetes
Guazzi, M., Oreglia, I., & Guazzi, M. D. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1802 · Cited by 38
Modulation of adipocyte lipoprotein lipase expression as a strategy for preventing or treating visceral obesity
McCarty, M. F. (2001) · Medical Hypotheses · doi:10.1054/mehy.2001.1317 · Cited by 38
Chronic withdrawal of a high-palatable obesity-inducing diet completely reverses metabolic and vascular abnormalities associated with dietary-obesity in the rat
Naderali, E. K., Fatani, S. H., & Williams, G. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.09.021 · Cited by 38
Palmitate induces C-reactive protein expression in human aortic endothelial cells. Relevance to fatty acid–induced endothelial dysfunction
Mugabo, Y., Mukaneza, Y., & Renier, G. (2010) · Metabolism · doi:10.1016/j.metabol.2010.06.014 · Cited by 36
The Role of High-Density Lipoproteins in Endothelial Cell Metabolism and Diabetes-Impaired Angiogenesis
Primer, K., Psaltis, P. J., Tan, J. T. M., & Bursill, C. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103633 · Cited by 38
AMPK activation as a strategy for reversing the endothelial lipotoxicity underlying the increased vascular risk associated with insulin resistance syndrome
McCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.01.042 · Cited by 35
Mechanisms underlying the losartan treatment-induced improvement in the endothelial dysfunction seen in mesenteric arteries from type 2 diabetic rats
Matsumoto, T., Ishida, K., Nakayama, N., Taguchi, K., Kobayashi, T., & Kamata, K. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.03.003 · Cited by 35
Pioglitazone increases non-esterified fatty acid clearance in upper body obesity
Shadid, S., & Jensen, M. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0051-0 · Cited by 35
Relation of Plasma Insulin Levels to Forearm Flow-Mediated Dilatation in Healthy Volunteers
Ardigò, D., Franzini, L., Valtueña, S., Monti, L. D., Reaven, G. M., & Zavaroni, I. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.11.047 · Cited by 35
ICU care for patients with diabetes
Umpierrez, G. E., & Kitabchi, A. E. (2004) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000129636.04145.84 · Cited by 35
Effect of fatty acids on endothelium-dependent relaxation in the rabbit aorta
Edirisinghe, I., Hallam, K. M., & Kappagoda, C. T. (2006) · Clinical Science · doi:10.1042/cs20060001 · Cited by 33
Palmitic and Linoleic Acids Impair Endothelial Progenitor Cells by Inhibition of Akt/eNOS Pathway
Guo, W., Yang, Q., Liu, Y.-H., Xie, X., Wang-Miao, & Niu, R. (2008) · Archives of Medical Research · doi:10.1016/j.arcmed.2008.02.001 · Cited by 34
Periodontal disease is associated with metabolic syndrome in hemodialysis patients
Chen, L., Hsu, S.-P., Peng, Y. S., Chiang, C., & Hung, K. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr209 · Cited by 34
FFAs: Do they play a role in vascular disease in the insulin resistance syndrome?
Shankar, S. S., & Steinberg, H. O. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0064-6 · Cited by 34
Self-citation
Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease
Fragasso, G., Piatti, P. M., Monti, L. D., Palloshi, A., Lu, C., Valsecchi, G., Setola, E., Calori, G., Pozza, G., Margonato, A., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01768-5 · Cited by 34
Endothelial Acyl-CoA Synthetase 1 Is Not Required for Inflammatory and Apoptotic Effects of a Saturated Fatty Acid-Rich Environment
Li, X., Gonzalez, O. A., Shen, X., Barnhart, S., Kramer, F., Kanter, J. E., Vivekanandan‐Giri, A., Tsuchiya, K., Handa, P., Pennathur, S., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.252239 · Cited by 33
Vascular effects of intravenous intralipid and dextrose infusions in obese subjects
Gosmanov, A. R., Smiley, D. D., Peng, L., Siquiera, J., Robalino, G., Newton, C. A., & Umpierrez, G. E. (2012) · Metabolism · doi:10.1016/j.metabol.2012.03.006 · Cited by 34
The effect of a mixed meal on endothelium-dependent vasodilation is dependent on fat content in healthy humans
Steer, P., Sarabi, D. M., Karlström, B., Basu, S., Berne, C., Vessby, B. O., & Lind, L. (2003) · Clinical Science · doi:10.1042/cs20020327 · Cited by 33
Birth weight and renal function
Tulassay, T., & Vásárhelyi, B. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200205000-00013 · Cited by 33
Differential modulation of citrate synthesis and release by fatty acids in perfused working rat hearts
Vincent, G., Bouchard, B., Khairallah, M., & Rosiers, C. D. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00717.2003 · Cited by 33
Is the fatty meal a trigger for acute coronary syndromes.
Anderson, R. A., Jones, C., & Goodfellow, J. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00669-4 · Cited by 34
Impact of body composition on very-low-density lipoprotein-triglycerides kinetics
Gormsen, L. C., Nellemann, B., Sørensen, L. P., Jensen, M. D., Christiansen, J. S., & Nielsen, S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90675.2008 · Cited by 32
Palmitate‐Stimulated Monocytes Induce Adhesion Molecule Expression in Endothelial Cells via IL‐1 Signaling Pathway
Shikama, Y., Aki, N., Hata, A., Nishimura, M., Oyadomari, S., & Funaki, M. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24797 · Cited by 32
Metabolic Profiling and Metabolites Fingerprints in Human Hypertension: Discovery and Potential
Onuh, J. O., & Qiu, H. (2021) · Metabolites · doi:10.3390/metabo11100687 · Cited by 32
Up-regulation of PPARγ coactivator-1α as a strategy for preventing and reversing insulin resistance and obesity
McCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.03.034 · Cited by 32
Desequilíbrio autonômico e síndrome metabólica: parceiros patológicos em uma pandemia global emergente
Lopes, H. F., & Egan, B. M. (2006) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2006001700022 · Cited by 33
Lipids and lipoproteins and inflammatory markers in patients with chronic apical periodontitis
Kimak, A., Strycharz-Dudziak, M., Bachanek, T., & Kimak, E. (2015) · Lipids in Health and Disease · doi:10.1186/s12944-015-0156-5 · Cited by 32
Response to pioglitazone treatment is associated with the lipoprotein lipase S447X variant in subjects with type 2 diabetes mellitus
Wang, G., Wang, X., Zhang, Q., & Ma, Z. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01242.x · Cited by 31
Magnesium infusion improves endothelium-dependent vasodilation in the human forearm
Haenni, A., Johansson, K., Lind, L., & Lithell, H. (2002) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02225-7 · Cited by 31
Coronary microvascular disease: The “Meeting Point” of Cardiology, Rheumatology and Endocrinology
Markousis‐Mavrogenis, G., Bacopoulou, F., Mavragani, C. P., Voulgari, P. V., Kolovou, G. D., Kitas, G. D., Chrousos, G. P., & Mavrogeni, S. I. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13737 · Cited by 31
Pharmacological approaches to coronary microvascular dysfunction
Guarini, G., Huqi, A., Morrone, D., Capozza, P., Todiere, G., & Marzilli, M. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.06.008 · Cited by 31
Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients
Panunti, B. A., & Fonseca, V. A. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2005.11.013 · Cited by 30
Effect of Keishibukuryogan on Endothelial Function in Patients with at Least One Component of the Diagnostic Criteria for Metabolic Syndrome: A Controlled Clinical Trial with Crossover Design
Nagata, Y., Goto, H., HIKIAMI, H., Nogami, T., Fujimoto, M., Shibahara, N., & Shimada, Y. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/359282 · Cited by 29
l‐Carnitine May Attenuate Free Fatty Acid‐Induced Endothelial Dysfunction
Shankar, S. S., Mirzamohammadi, B., WALSH, J. P., & Steinberg, H. O. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1320.018 · Cited by 28
Self-citation
Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients
Faria, A. N., Filho, F. F. R., Kohlmann, N. E. B., Ferreira, S. R. G., & Zanella, M. T. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00465.x · Cited by 29
Differential regulations of blood pressure and perturbed metabolism by total ginsenosides and conventional antihypertensive agents in spontaneously hypertensive rats
Aa, J., Wang, G., Hao, H., Huang, Q. B., Lu, Y., Yan, B., Zha, W., Liu, L., & An, K. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.86 · Cited by 28
Elevated non-esterified fatty acids impair nitric oxide independent vasodilation, in humans: evidence for a role of inwardly rectifying potassium channels
de Kreutzenberg, S. V., Puato, M., Kiwanuka, E., Prato, S. D., Pauletto, P., Pasini, L., Tiengo, A., & Avogaro, A. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00153-9 · Cited by 28
Effect of Insulin Therapy on Nonglycemic Variables During Acute Illness
Hirsch, I. B. (2004) · Endocrine Practice · doi:10.4158/ep.10.s2.63 · Cited by 28
Protective effects of a compound herbal extract (Tong Xin Luo) on free fatty acid induced endothelial injury: Implications of antioxidant system
Zhang, L., Wu, Y., Jia, Z., Zhang, Y., Shen, Y. H., & Wang, X. L. (2008) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-8-39 · Cited by 27
Free fatty acids are associated with insulin resistance but not coronary artery atherosclerosis in rheumatoid arthritis
Ormseth, M. J., Swift, L. L., Fazio, S., Linton, M. F., Chung, C. P., Raggi, P., Rho, Y. H., Solus, J. F., Oeser, A. M., Bian, A., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.09.005 · Cited by 28
Adiponectin resistance and vascular dysfunction in the hyperlipidemic state
Li, R., Lau, W. B., & Liang, X. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.95 · Cited by 28
Effect of inositol and its derivatives on diabetes: a systematic review
Özturan-Şirin, A., Arslan, S., Bozkurt, B. K., Elibol, E., İmamoğlu, İ., & Karadağ, M. G. (2017) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1392926 · Cited by 28
Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents
Dandona, P., & Aljada, A. (2004) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00259-3 · Cited by 28
The role of glycated hemoglobin (HbA1c) and serum lipid profile measurements to detect cardiovascular diseases in type 2 diabetic patients
Naeem, M. T., Khattak, R. M., Rehman, M. U., & Khattak, M. N. K. (2016) · South East Asia Journal of Public Health · doi:10.3329/seajph.v5i2.28310 · Cited by 28
Review of management in cardiotoxic overdose and efficacy of delayed intralipid use
Walter, E. J., McKinlay, J., Corbett, J., & Kirk-Bayley, J. (2017) · Journal of the Intensive Care Society · doi:10.1177/1751143717705802 · Cited by 27
Identifying lipid traces of atherogenic mechanisms in human carotid plaque
Slijkhuis, N., Towers, M. W., Mirzaian, M., Korteland, S.-A., Heijs, B., van Gaalen, K., Nieuwenhuizen, I. M., Nigg, A. L., der Heiden, K. V., de Rijke, Y. B., et al. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117340 · Cited by 27
Dihydropyridine calcium channel blockers inhibit non-esterified-fatty-acid-induced endothelial and rheological dysfunction
Yasu, T., Kobayashi, M., Mutoh, A., Yamakawa, K., Momomura, S., & Ueda, S. (2013) · Clinical Science · doi:10.1042/cs20120311 · Cited by 27
Flavanol-rich cocoa ameliorates lipemia-induced endothelial dysfunction
Westphal, S., & Luley, C. H. (2010) · Heart and Vessels · doi:10.1007/s00380-010-0085-1 · Cited by 27
Free Fatty acids (FFA) and endothelial dysfunction; role of increased oxidative stress and inflammation
Tripathy, D., Aljada, A., & Dandona, P. (2003) · Diabetologia · doi:10.1007/s00125-002-1027-y · Cited by 27
Vascular Endothelium in Health and Disease: Structure, Function, Assessment and Role in Metabolic Disorders
Pluta, W. W., Lubkowska, A., & Dudzińska, W. (2025) · Vascular Health and Risk Management · doi:10.2147/vhrm.s519426 · Cited by 35
The Distinctive Nature of Atherosclerotic Vascular Disease in Diabetes: Pathophysiological and Morphological Insights
Puri, R., Kataoka, Y., Uno, K., & Nicholls, S. J. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0270-y · Cited by 26
Association of plasma free fatty acids levels with the presence and severity of coronary and carotid atherosclerotic plaque in patients with type 2 diabetes mellitus
Zhang, M., Cao, Y., Wu, L., Guo, N., Hou, B., Sun, L., Guo, Y., Wu, N., Dong, Q., & Li, J. (2020) · BMC Endocrine Disorders · doi:10.1186/s12902-020-00636-y · Cited by 26
The dynamics of the microcirculation in the subcutaneous adipose tissue is impaired in the postprandial state in type 2 diabetes
Tobin, L., Simonsen, L., & Bülow, J. (2011) · Clinical Physiology and Functional Imaging · doi:10.1111/j.1475-097x.2011.01041.x · Cited by 28
Endurance exercise in a rat model of metabolic syndrome
Cameron, I., Alam, M. A., Wang, J., & Brown, L. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-097 · Cited by 26
Role of oxidative stress in elevated blood pressure induced by high free fatty acids
Wang, H., Li, H., Hou, Z., Pan, L., Shen, X., & Li, G. (2009) · Hypertension Research · doi:10.1038/hr.2008.35 · Cited by 26
Leptin and the Adipocyte Endocrine System
Diamond, F., & Eichler, D. C. (2002) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360290795565 · Cited by 27
Vascular endothelium is the organ chiefly responsible for the catabolism of plasma asymmetric dimethylarginine – an explanation for the elevation of plasma ADMA in disorders characterized by endothelial dysfunction
McCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2002.11.008 · Cited by 26
Vascular dysfunction and myocardial contractility in the JCR:LA-corpulent rat
Brünner, F. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00056-0 · Cited by 26
Insulin resistance but not hypertriglyceridemia per se is associated with endothelial dysfunction in chronic hypertriglyceridemia
Jonkers, I. J. A. M. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00504-1 · Cited by 26
Insulin resistance in Type 2 diabetes and obesity: implications for endothelial function
Aziz, A., & Wheatcroft, S. B. (2011) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.11.20 · Cited by 25
Effect of syncytiotrophoblast microvillous membrane treatment on gene expression in human umbilical vein endothelial cells
Hoegh, A. M., Tannetta, D., Sargent, I. L., Borup, R., Nielsen, F. C., Redman, C. W. G., Sørensen, S., & Hviid, T. (2006) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2006.01061.x · Cited by 25
Kakkalide ameliorates endothelial insulin resistance by suppressing reactive oxygen species‐associated inflammation (葛花苷通过抑制活性氧相关的炎症改善内皮细胞胰岛素抵抗)
Zhang, D., Gao, X., Wang, Q., Qin, M., Liu, K., Huang, F., & Liu, B. (2012) · Journal of Diabetes · doi:10.1111/1753-0407.12017 · Cited by 25
Antiobesogenic Role of Endothelial Nitric Oxide Synthase
Sansbury, B. E., & Hill, B. G. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800254-4.00013-1 · Cited by 26
Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance
Cree‐Green, M., Wiromrat, P., Stuppy, J. J., Thurston, J. E., Bergman, B. C., Baumgartner, A., Bacon, S. D., Scherzinger, A. L., Pyle, L. L., & Nadeau, K. J. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00258.2018 · Cited by 25
Effects of a high‐fat meal on resistance vessel reactivity and on indicators of oxidative stress in healthy volunteers
Schinkovitz, A., Dittrich, P., & Wascher, T. C. (2001) · Clinical Physiology · doi:10.1046/j.1365-2281.2001.00341.x · Cited by 25
Stress Hyperglycemia Does Not Affect Clinical Outcome of Diabetic Patients Receiving Intravenous Thrombolysis for Acute Ischemic Stroke
Merlino, G., Pez, S., Tereshko, Y., Gigli, G. L., Lorenzut, S., Surcinelli, A., & Valente, M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.903987 · Cited by 24
The long-term ingestion of a diet high in extra virgin olive oil produces obesity and insulin resistance but protects endothelial function in rats: a preliminary study
Keita, H., Juan, E. R., Paniagua‐Castro, N., Garduño‐Siciliano, L., & Quevedo, L. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-53 · Cited by 24
Monounsaturated fatty acids protect against palmitate-induced lipoapoptosis in human umbilical vein endothelial cells
Lee, D. M., Sevits, K. J., Battson, M. L., Wei, Y., Cox‐York, K. A., & Gentile, C. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226940 · Cited by 23
Plasma antioxidants and oxidative stress status in obese women: correlation with cardiopulmonary response
Adenan, D. M., Jaafar, Z., Jayapalan, J. J., & Aziz, A. A. (2020) · PeerJ · doi:10.7717/peerj.9230 · Cited by 25
Non-esterified fatty acids impair endothelium-dependent vasodilation in rat mesenteric resistance vessels
Sainsbury, C. A. R., Sattar, N. A., Connell, J., Hillier, C., & Petrie, J. R. (2004) · Clinical Science · doi:10.1042/cs20040140 · Cited by 24
Free fatty acids as target for therapy
Boden, G. H. (2004) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000141928.95173.63 · Cited by 24
Selective aspects of the insulin resistance syndrome
Corry, D. B., & Tuck, M. L. (2001) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200107000-00005 · Cited by 24
Why Does Obesity Increase the Risk for Cardiovascular Disease?
Boden, G. H., & Salehi, S. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319320003 · Cited by 23
Remnant Cholesterol, a Valuable Biomarker for Assessing Arteriosclerosis and Cardiovascular Risk: A Systematic Review
Chen, X., & Li, L. (2023) · Cureus · doi:10.7759/cureus.44202 · Cited by 26
The Pathogenesis of Diabetic Atherosclerosis
Siracuse, J. J., & Chaikof, E. L. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-158-5_2 · Cited by 23
Sympathetic and haemodynamic responses to lipids in healthy human ageing
Florian, J. P., & Pawelczyk, J. A. (2010) · Experimental Physiology · doi:10.1113/expphysiol.2009.050997 · Cited by 23
Cilostazol improves endothelial dysfunction by increasing endothelium-derived hyperpolarizing factor response in mesenteric arteries from Type 2 diabetic rats
Matsumoto, T., Noguchi, E., Ishida, K., Nakayama, N., Kobayashi, T., & Kamata, K. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.10.006 · Cited by 23
Regular Aerobic, Resistance, and Cross-Training Exercise Prevents Reduced Vascular Function Following a High Sugar or High Fat Mixed Meal in Young Healthy Adults
Das, E., Lai, P. Y., Robinson, A. T., Pleuss, J. A., Ali, M. M., Haus, J. M., Gutterman, D. D., & Phillips, S. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00183 · Cited by 23
Thiazolidinediones—improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes
Dandona, P., Ghanim, H., Chaudhuri, A., & Mohanty, P. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.10.009 · Cited by 23

Authors: Steinberg, H. O., Tarshoby, M., Monestel, R., Hook, G., Cronin, J., Johnson, A., Bayazeed, B., & Baron, A. D.
Affiliations: Indiana University (US)
Indiana University – Purdue University Indianapolis (US)
ORCID: Tarshoby, M
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1997-09-01
Volume: 100
Issue: 5
Pages: 1230-1239
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci119636
PMC: PMC508300
OpenAlex: W2086785365
Cited by: 761
References: 16
Citations by year: 2026: 6 · 2025: 12 · 2024: 17 · 2023: 20 · 2022: 9 · 2021: 19 · 2020: 29 · 2019: 11 · 2018: 19 · 2017: 20 · 2016: 12 · 2015: 22 · 2014: 17 · 2013: 28 · 2012: 33
FWCI: 10.61
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: U.S. Department of Veterans Affairs
American Heart Association
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (DK 20452, DK42469)
National Center for Research Resources (MO1-RR75019)
Topics: Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: free fatty acids, endothelial dysfunction, endothelium-dependent vasodilation, insulin resistance, methacholine, sodium nitroprusside, leg blood flow, somatostatin, insulin deficiency, Intralipid, obesity, insulin replacement therapy
MeSH terms: Adult, Blood Pressure, Endothelium, Vascular, Fat Emulsions, Intravenous, Fatty Acids, Nonesterified, Female, Humans, Insulin, Leg, Male, Nitroprusside, Somatostatin, Vasodilation, Methacholine Chloride

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks